417 related articles for article (PubMed ID: 33805951)
1. Endocannabinoid System Dysregulation from Acetaminophen Use May Lead to Autism Spectrum Disorder: Could Cannabinoid Treatment Be Efficacious?
Schultz S; Gould GG; Antonucci N; Brigida AL; Siniscalco D
Molecules; 2021 Mar; 26(7):. PubMed ID: 33805951
[TBL] [Abstract][Full Text] [Related]
2. Can autism be triggered by acetaminophen activation of the endocannabinoid system?
Schultz ST
Acta Neurobiol Exp (Wars); 2010; 70(2):227-31. PubMed ID: 20628445
[TBL] [Abstract][Full Text] [Related]
3. Potential of cannabinoids as treatments for autism spectrum disorders.
Nezgovorova V; Ferretti CJ; Taylor BP; Shanahan E; Uzunova G; Hong K; Devinsky O; Hollander E
J Psychiatr Res; 2021 May; 137():194-201. PubMed ID: 33689997
[TBL] [Abstract][Full Text] [Related]
4. Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations.
Brigida AL; Schultz S; Cascone M; Antonucci N; Siniscalco D
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28671614
[TBL] [Abstract][Full Text] [Related]
5. The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease.
Han QW; Yuan YH; Chen NH
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109745. PubMed ID: 31442553
[TBL] [Abstract][Full Text] [Related]
6. Endocannabinoids in the gastrointestinal tract.
Lee Y; Jo J; Chung HY; Pothoulakis C; Im E
Am J Physiol Gastrointest Liver Physiol; 2016 Oct; 311(4):G655-G666. PubMed ID: 27538961
[TBL] [Abstract][Full Text] [Related]
7. Implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: A literature review.
de Camargo RW; de Novais Júnior LR; da Silva LM; Meneguzzo V; Daros GC; da Silva MG; de Bitencourt RM
Pharmacol Biochem Behav; 2022 Nov; 221():173492. PubMed ID: 36379443
[TBL] [Abstract][Full Text] [Related]
8. An Introduction to the Endogenous Cannabinoid System.
Lu HC; Mackie K
Biol Psychiatry; 2016 Apr; 79(7):516-25. PubMed ID: 26698193
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological inhibition of the primary endocannabinoid producing enzyme, DGL-α, induces autism spectrum disorder-like and co-morbid phenotypes in adult C57BL/J mice.
Fyke W; Alarcon JM; Velinov M; Chadman KK
Autism Res; 2021 Jul; 14(7):1375-1389. PubMed ID: 33886158
[TBL] [Abstract][Full Text] [Related]
10. Distribution of the Endocannabinoid System in the Central Nervous System.
Hu SS; Mackie K
Handb Exp Pharmacol; 2015; 231():59-93. PubMed ID: 26408158
[TBL] [Abstract][Full Text] [Related]
11. Hemopressin Peptides as Modulators of the Endocannabinoid System and their Potential Applications as Therapeutic Tools.
Macedonio G; Stefanucci A; Maccallini C; Mirzaie S; Novellino E; Mollica A
Protein Pept Lett; 2016; 23(12):1045-1051. PubMed ID: 27748182
[TBL] [Abstract][Full Text] [Related]
12. Lower circulating endocannabinoid levels in children with autism spectrum disorder.
Aran A; Eylon M; Harel M; Polianski L; Nemirovski A; Tepper S; Schnapp A; Cassuto H; Wattad N; Tam J
Mol Autism; 2019; 10():2. PubMed ID: 30728928
[TBL] [Abstract][Full Text] [Related]
13. The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models.
Zamberletti E; Gabaglio M; Parolaro D
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28880200
[TBL] [Abstract][Full Text] [Related]
14. Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB
Navarro G; Borroto-Escuela D; Angelats E; Etayo Í; Reyes-Resina I; Pulido-Salgado M; Rodríguez-Pérez AI; Canela EI; Saura J; Lanciego JL; Labandeira-García JL; Saura CA; Fuxe K; Franco R
Brain Behav Immun; 2018 Jan; 67():139-151. PubMed ID: 28843453
[TBL] [Abstract][Full Text] [Related]
15. The endocannabinoid system.
Kilaru A; Chapman KD
Essays Biochem; 2020 Sep; 64(3):485-499. PubMed ID: 32648908
[TBL] [Abstract][Full Text] [Related]
16. Healing autism spectrum disorder with cannabinoids: a neuroinflammatory story.
Carbone E; Manduca A; Cacchione C; Vicari S; Trezza V
Neurosci Biobehav Rev; 2021 Feb; 121():128-143. PubMed ID: 33358985
[TBL] [Abstract][Full Text] [Related]
17. Unraveling the Endocannabinoid System: Exploring Its Therapeutic Potential in Autism Spectrum Disorder.
Jana A; Nath A; Sen P; Kundu S; Alghamdi BS; Abujamel TS; Saboor M; Woon-Khiong C; Alexiou A; Papadakis M; Alam MZ; Ashraf GM
Neuromolecular Med; 2024 May; 26(1):20. PubMed ID: 38744725
[TBL] [Abstract][Full Text] [Related]
18. Alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder.
Zou M; Liu Y; Xie S; Wang L; Li D; Li L; Wang F; Zhang Y; Xia W; Sun C; Wu L
Open Biol; 2021 Feb; 11(2):200306. PubMed ID: 33529552
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoid markers in autism spectrum disorder: A scoping review of human studies.
De Pol M; Kolla NJ
Psychiatry Res; 2021 Dec; 306():114256. PubMed ID: 34775294
[TBL] [Abstract][Full Text] [Related]
20. Acetaminophen Use for Fever in Children Associated with Autism Spectrum Disorder.
Schultz ST; Gould GG
Autism Open Access; 2016 Apr; 6(2):. PubMed ID: 27695658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
